L

LUX Infusion

Outpatient infusion centers for IV therapies

Home Infusion Nurse

Full-TimeUpdated on 10/23/2026
$55 - $65
Mid
Bachelor's
San Diego, CA, USA
In PersonWork in patients’ homes in the San Diego, California area; travel to patient homes is required.
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • A nursing degree from an accredited college is required.
  • IV certification and experience in central line care and management are required.
  • A current state registered nurse license is required; licenses in other states are a plus.
  • A valid state driver's license is required.
  • Experience with medical terminology is required.
  • Experience in home care, critical care, emergency nursing, AIC, or hospital discharge planning is required.
  • Some staffing experience is required, along with the ability to multitask and effective communication and interpersonal skills.
  • Basic proficiency in Microsoft Office, including Word, Excel, and PowerPoint, is required.
  • Must be willing to travel to patients' homes and other health care settings.
  • Experience providing customer service to internal and external customers, meeting service quality standards, and evaluating customer satisfaction is required.
  • Current CPR certification is required.
  • Must be able to prioritize and handle multiple tasks and projects, work extra hours when needed, and maintain careful attention to detail.
  • Must provide professional nursing care, coordinate care planning with other disciplines, and provide care addressing patients' psychosocial, physical, and general needs.
  • Must determine care priorities based on patients' physical and psychosocial needs and factors affecting patient flow.
  • Must communicate changes in patient status, symptoms, and diagnostic study results, and respond promptly and accurately to changes in condition or treatment response.
  • Must possess medical-surgical experience or knowledge of phlebotomy and venous access.
  • Must be able to work independently and as part of a team.
  • Must teach patients how to care for their IV or PICC line and communicate instructions clearly.
  • Must be able to work under high stress and handle critical situations.
  • Must demonstrate oral and written communication skills, including clear speaking and writing, listening, clarification, responding to questions, presenting to groups, participating in meetings, editing for spelling and grammar, adapting writing style, presenting numerical data, and interpreting written information.
  • Must become and remain proficient in all computer programs necessary to perform the role.
  • Must participate annually in required legal and ethical compliance training, follow the company's legal, ethical, and compliance policies and manual, and refrain from unethical or unlawful behavior.
Responsibilities
  • Insert, monitor, and remove intravenous lines used to administer medications, blood products, and nutrition, monitoring patients for adverse reactions and ensuring tubing, bandages, and needles remain in place.
  • Perform venous phlebotomy when patient blood levels need to be checked.
  • Obtain vital signs, complete physical assessments and reviews of systems, document patient-related activities, and record medications used throughout infusion therapy.
  • Provide and coordinate staffing services for patients with support from company directors, the nursing coordinator, and the director of nursing.
  • Communicate with patients to identify problems and solutions related to their treatment.
  • Provide patient documentation to relevant internal and external staff regarding scheduling and other pertinent patient information.
  • Perform clinical duties and nursing documentation, including planning, organizing, scheduling, and coordinating patient care delivery by staff and submitting complete nursing notes.
  • Use the nursing process to schedule nursing visits in accordance with prescriptions and established protocols.
  • Coordinate start-of-care and ongoing nursing visits, and confirm visits with patients and the nursing agency or registered nurse.
  • Send schedules to the team by email.
  • Follow up on therapy administration reports, enter them, and email them to the team.
  • Review nurses' notes for content, accuracy, and completeness, including drugs administered, dosages, and administration times.
  • Maintain ongoing communication with families, supervisors, field personnel, and agencies about patient problems and special needs.
  • Report problems and reportable situations to the referring physician, the appropriate physician's office administrator, and LUX Infusion nursing staff.
  • Perform computer functions, including data entry, reports, and searches.
  • Communicate patient and employee information to answering services when required.
  • Coordinate staffing promptly while maintaining confidentiality and following compliance and ethics requirements.
  • Insert intravenous cannulas, administer prescribed intravenous solutions and medications, maintain infusion sites and systems, and evaluate responses to prescribed therapy.
  • Teach patients and caregivers to administer and monitor home infusion therapy.
  • Prepare clinical records, care plans, and progress notes for each patient.
  • Coordinate patient visit schedules and phone calls.
  • Work in patients' places of residence and drive as assigned.
  • Participate in quality assurance activities and audits as directed.
  • Prioritize competing demands, manage multiple tasks, and seek guidance when appropriate.
  • Assist directly or coordinate assistance to ensure people with disabilities can access the organization's services.
Desired Qualifications
  • A bachelor's degree is preferred.
  • A registered nurse degree and licensure are preferred.
  • Experience with medical terminology is preferred.

About the company

LUX Infusion provides ambulatory infusion services in Alaska, delivering IV and injectable therapies outside hospital settings in spa-like centers in Anchorage, Palmer, and Fairbanks. A clinical team of physicians, nurse practitioners, and infusion nurses collaborates with referring providers, while centers handle pre-authorizations and financial assistance, serving patients with private insurance, Medicare, and Medicaid. In 2025, LUX Infusion was acquired by BioMatrix Infusion Pharmacy, integrating its care teams into a national ambulatory infusion network to expand the Pacific Northwest and accelerate growth; the company holds NICA accreditation and the AICE-Ambulatory Infusion Center of Excellence designation. Its goal is to provide high-quality, patient-centered outpatient infusion care that reduces medical costs and offers an alternative to hospital-based treatment.

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Anchorage, Alaska

Founded

2022

Get referred to LUX Infusion

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 6, 2026 Infuse IQ acquisition adds Wyoming sites and widens referral reach.
  • May 28, 2026 promotion of Dan Teich strengthens market-access negotiations with payors and manufacturers.
  • Home infusion plus ambulatory care creates cross-referral opportunities and more therapy starts than hospital sites.

What critics are saying

  • Biomatrix integration can standardize LUX away, erasing local brand distinction by 2027.
  • Infuse IQ’s August 6, 2026 acquisition stretches management and capital across Wyoming and Alaska.
  • Specialty infusion reimbursement pressure from payors and manufacturers can compress margins if contracts reset in 2027.

What makes LUX Infusion unique

  • Alaska’s only scaled ambulatory infusion footprint in Anchorage, Palmer, and Fairbanks anchors local density.
  • Clinician-led, spa-like infusion centers with NICA and AICE designations signal differentiated patient experience.
  • BioMatrix acquired LUX on October 17, 2025, plugging it into national specialty-infusion infrastructure.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Company News

PR Newswire
Oct 15th, 2026
LUX Infusion enters Colorado with acquisition of Loveland-based Suite Health

LUX Infusion, a clinician-led infusion services company based in Plantation, Florida, has acquired Suite Health, a specialty infusion therapy provider in Loveland, Colorado. The deal, announced October 15, 2026, marks LUX Infusion's entry into Colorado. Suite Health's local clinical team is known for patient support and responsive referral coordination. LUX Infusion will add clinical, operational, and technological resources while keeping Suite Health's personalised approach. "Our role is to build on that foundation," said Ted Kramm, chief executive officer of LUX Infusion. He said the aim is to make it easier for more patients to access infusion care in the setting that suits them best. LUX Infusion is a portfolio company of Frazier Healthcare Partners. The source gave no financial terms.

PR Newswire
Oct 9th, 2026
LUX Infusion adds Qfitlia to hemophilia treatment portfolio, expanding access for patients 12 and older

LUX Infusion, a US-based clinician-led infusion service network, announced it is now authorised to dispense Qfitlia (fitusiran), expanding access to hemophilia treatment. The subcutaneous therapy is for patients aged 12 and older with hemophilia A or B, with or without Factor VIII or IX inhibitors, requiring routine bleed prevention treatment. The company provides comprehensive support throughout the treatment process, including benefit navigation and 24/7 on-call guidance. LUX Infusion pairs each patient with a dedicated contact who has bleeding disorder experience and works closely with Hemophilia Treatment Centers. "Adding Qfitlia to our portfolio enables us to offer a unique treatment option that is fully supported by our high-touch model," said Ted Kramm, chief executive officer of LUX Infusion.

Access Market Intelligence
Aug 30th, 2026
Specialty Pharmacy news roundup: august 2026.

Specialty Pharmacy news roundup: august 2026. The following are just a few of the many recent specialty pharmacy activities during the past month. Biologics by McKesson, an independent specialty pharmacy specializing in oncology, cell and gene, and rare disease therapies, has been selected by Cycle Pharmaceuticals as a limited distribution specialty pharmacy provider for CAVHANZA (nilotinib) Orally Disintegrating Tablets. CAVHANZA is a tyrosine kinase inhibitor indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase; and/or adult patients with chronic phase (CP) and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib. Biologics by McKesson has also been selected by Revolution Medicines as a specialty pharmacy provider for RASONQUE (daraxonrasib) within its distribution network. RASONQUE is an oral therapy approved for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. Carepoint Pharmacy, an end-to-end access hub and dispensing pharmacy serving patients nationwide, announced a new partnership with and investment from New Heritage Capital, a Boston-based private equity firm focused on partnering with high-growth, founder-owned businesses. The investment was structured using Heritage's Private IPO solution, which leaves operating control in the hands of current Carepoint management while providing the financial flexibility to accelerate future growth. LUX Infusion, a clinician-led infusion services company, announced the acquisition of Infuse IQ, a trusted Wyoming-headquartered independent infusion therapy provider delivering safe, personalized infusion and injection treatments across a broad range of medical specialties. The acquisition expands LUX Infusion's ambulatory infusion network and strengthens its ability to serve patients and referring providers in communities across the country. Onco360, the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU (vepdegestrant), which is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy. Onco360 has also been selected as a pharmacy partner by Revolution Medicines for RASONQUE (daraxonrasib), which is an inhibitor of the RAS GTPase family, indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. PANTHERx Rare has been selected by Intercept Pharmaceuticals, Inc., a wholly owned subsidiary of Alfasigma S.p.A., as the exclusive U.S. specialty pharmacy partner to distribute LYNAVOY (linerixibat), the first FDA-approved treatment specifically indicated for cholestatic pruritus in adults with primary biliary cholangitis (PBC). This collaboration underscores the company's commitment to innovative rare disease care and its mission to reduce barriers for patients facing complex conditions. PANTHERx Rare has also been selected by Vera Therapeutics, Inc. to dispense TRUTAKNA (atacicept-vymj), an FDA-approved treatment indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression. IgAN is a complex, progressive kidney disease, and timely access to treatment can make a meaningful difference. The company's team is committed to helping patients navigate access, stay on therapy, and receive personalized support every step of the way. You can find even more news and insights by subscribing to AMI's Specialty Pharmacy Database. Keep up with accreditations earned, key decision-maker changes, mergers and acquisitions and MORE.

PR Newswire
Aug 6th, 2026
LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint

/PRNewswire/ -- LUX Infusion, a clinician-led infusion services company, today announced the acquisition of Infuse IQ, a trusted Wyoming-headquartered...

LUX Infusion
May 28th, 2026
LUX Infusion promotes Dan Teich to Senior Vice President, Market Access.

LUX Infusion promotes Dan Teich to Senior Vice President, Market Access. Unified leadership role aligns trade relations and managed care to strengthen distribution, manufacturer, and payor partnerships. [Plantation, FL] - May 28, 2026 - LUX Infusion, a U.S.-based, clinician-led infusion services company, today announced the promotion of Dan Teich to Senior Vice President, Market Access. In this expanded role, Teich will lead a unified market access function that brings together the company's trade relations and managed care operations under a single, cohesive strategy designed to deepen alignment with LUX Infusion's distribution, manufacturer, and payor partners. "Dan has been an exceptional leader in shaping our trade relationships, and this promotion reflects both his contributions and our confidence in his vision," said Ted Kramm, Chief Executive Officer of LUX Infusion. "By unifying trade relations and managed care under his leadership, we are creating a more integrated approach to how we work with our partners, positioning LUX Infusion to deliver greater value across the entire specialty infusion ecosystem." As SVP, Market Access, Teich will be responsible for developing and executing a comprehensive strategy that aligns the company's market access partnerships across pharmaceutical manufacturers, specialty distributors, group purchasing organizations, and health plan payors with LUX Infusion's mission to expand patient access to high-quality, accessible infusion care. Teich brings more than 15 years of expertise in pharmacy operations, supply chain management, contract negotiation, and executive leadership across the specialty infusion, health system, and retail pharmacy sectors. Prior to joining LUX Infusion, he served as Vice President of Health Systems Manufacturer Relations at Cencora (formerly AmerisourceBergen), where he led negotiations of specialty and biosimilar GPO contracts for health systems, consistently exceeding fiscal-year performance targets. Before Cencora, Teich served as Vice President of Pharmacy Purchasing and Contracting at M Health Fairview, overseeing nearly $1 billion in annual drug spend and driving significant margin improvements through strategic contracting. As Program Manager of Home Infusion and Compounding at the same organization, he grew home infusion revenue by more than 240% over four years. He also held leadership roles at PharMerica and Walgreens. Teich holds a Doctor of Pharmacy (Pharm.D.) from North Dakota State University and has been a licensed pharmacist in Minnesota since 2007. "The convergence of trade relations and managed care under a unified market access function is a natural evolution for LUX Infusion as we scale nationally," said Teich. "I'm energized by the opportunity to work even more closely with our manufacturer, distribution, and payor partners to remove barriers and ensure patients receive the therapies they need, when and where they need them." This leadership structure reflects LUX Infusion's broader commitment to building a fully integrated infusion services platform that leverages strong partner relationships to drive superior clinical outcomes, operational efficiency, and expanded patient access as the company continues its growth toward more than 50 infusion locations nationwide. About LUX Infusion. LUX Infusion is elevating infusions into an experience. As a U.S. based, clinician-led infusion services company, it provides both home infusion and ambulatory infusion center services, bringing clarity, compassion, and expertise to every patient relationship. With faster therapy starts, dedicated patient support, and continuous data sharing with providers, LUX Infusion ensures patients feel supported, and providers and partners can trust in better adherence and outcomes. Media Contact: Tara Marchese Senior Director of Marketing, LUX Infusion Tel: 954-908-7636 Email: [email protected]